Pharma group asks USTR to drop India from watch list

12-02-2019

Pharma group asks USTR to drop India from watch list

fabioberti / Shutterstock.com

The lobby group for India’s pharma industry has asked the US Trade Representative (USTR) office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.


US Trade Representative, Indian Pharmaceutical Alliance, Indian Patent Office, priority watch list, patents, trademarks, compulsory licensing

LSIPR